Role of F18-FDG PET for monitoring of radiochemotherapy -- estimation of detectable number of tumour cells.

Abstract

BACKGROUND FDG-PET has been proven to be useful for the diagnosis of pancreatic cancer. However, no quantitative data exist concerning its sensitivity for treatment monitoring or early diagnosis. CASE REPORT We report on a 61-year-old patient with locally advanced cancer of the pancreas head who received sequential radiochemotherapy including gemcitabine… (More)

Topics

Cite this paper

@article{Ruf2004RoleOF, title={Role of F18-FDG PET for monitoring of radiochemotherapy -- estimation of detectable number of tumour cells.}, author={Juri Ruf and Holger Amthauer and Helmut Oettle and T H Steinm{\"{u}ller and Michail Plotkin and Uwe Pelzer and H J Scholman and Roland Felix and Peter Wust}, journal={Onkologie}, year={2004}, volume={27 3}, pages={287-90} }